Skip to main content
Clinical Trials/NCT02547051
NCT02547051UnknownNot Applicable

Dietary Factors and Disfluency. A Look Into Causes and Variations in Severity of Disfluency in Regards to Vocal Cord Tension.

The R2 Institute1 site in 1 country10 target enrollmentStarted: January 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
10
Locations
1
Primary Endpoint
Dietary Factors and Disfluency: Variations in Severity of Vocal Cord tension

Study Overview

Brief Summary

The purpose of this study is to see whether participants with persistent developmental disfluency who report fluctuational disfluency due to vocal cord tension on a day to day basis of can achieve a more normalized fluency by identifying dietary allergen responses and subsequently eliminating these dietary triggers from their daily consumption.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
16 Years to 75 Years (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Patients reporting persistent developmental disfluency.

Exclusion Criteria

  • •Patients reporting no changes in disfluency severity or frequency

Arms & Interventions

Food allergy and vocal cord tension

Experimental

To determine if dietary allergen responses and frequency and severity of vocal cord tension.

Intervention: Food Allergy Testing and Elimination Diet (Other)

Outcomes

Primary Outcomes

Dietary Factors and Disfluency: Variations in Severity of Vocal Cord tension

Time Frame: 1 Year

Initial fluency samples are taken prior to treatment protocol of study. Food sensitivity panel will be assessed for potential allergans. Allergan responses are graded from 0 being no response to food allergen to 3 being the strongest response and subsequent removal of sensitive allergan from diet. Speech sample and disfluency severity will be evaluated qualitatively again via the SSI-3 on repeat office visit at fixed interval scale. Erickson S-24 repeated at end of study and final conclusions made.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
The R2 Institute
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials